Liquidia (LQDA) Return on Capital Employed (2021 - 2026)
Liquidia (LQDA) posted quarterly Return on Capital Employed of 21.19% for Q1 2026, up 9717.0% year-over-year from 0.22% in Q1 2025, and up 168.54% quarter-over-quarter from 30.91% in Q4 2025.
Liquidia (LQDA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Liquidia's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 21.19% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 9717.0% year-over-year to 21.19%; the TTM figure through Mar 2026 stood at 21.19% (up 9717.0% YoY), while the FY2025 annual figure was 35.84%, up 5568.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 21.19%, up from 30.91% in the prior quarter.
- The five-year high for Return on Capital Employed was 21.19% in Q1 2026, with the low at 84.28% in Q2 2025.
- The 5-year median for Return on Capital Employed is 51.16% (2023), against an average of 49.13%.
- The sharpest annual moves came in 2023 and 2026: Return on Capital Employed plunged 4434 bps in 2023, then surged 9717 bps in 2026.
- Liquidia's Return on Capital Employed stood at 31.76% in 2022, then tumbled by 140 bps to 76.1% in 2023, then rose by 20 bps to 60.7% in 2024, then jumped by 49 bps to 30.91% in 2025, then surged by 169 bps to 21.19% in 2026.
- Business Quant data shows LQDA's Return on Capital Employed at 21.19% in Q1 2026, 30.91% in Q4 2025, and 65.51% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Liquidia | 6.31 Bn | 6.03 Bn | 160.92 Mn | 61.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.88% |
| Mar 31, 2026 | 21.19% |
| Dec 31, 2025 | -30.91% |
| Sep 30, 2025 | -65.51% |
| Jun 30, 2025 | -84.28% |
| Mar 31, 2025 | -75.98% |
| Dec 31, 2024 | -60.70% |
| Sep 30, 2024 | -61.57% |
| Jun 30, 2024 | -59.70% |
| Mar 31, 2024 | -68.45% |
| Dec 31, 2023 | -76.10% |
| Sep 30, 2023 | -51.16% |
| Jun 30, 2023 | -44.80% |
| Mar 31, 2023 | -27.43% |
| Dec 31, 2022 | -31.76% |
| Sep 30, 2022 | -33.99% |
| Jun 30, 2022 | -38.26% |
| Mar 31, 2022 | -45.85% |
| Dec 31, 2021 | -37.68% |
| Sep 30, 2021 | -40.25% |